SCHEMBL21701722

SCHEMBL21701722

N#Cc1ccc(-c2ccc3c(c2)C2(c4ccccc4Sc4ccccc42)c2cc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)ccc2-3)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.45
ABCG2 Q9UNQ0 7/20 0.43
MYC P01106 1/20 0.41
GABRA1 P14867 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
ALDH1A3 P47895 2/20 0.39
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ABCB1 P08183 5/20 0.38
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NTSR1 P30989 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21702217 1.00 PDK2 (0.45) PDK2ABCG2MYCGABRA1GABRG2
SCHEMBL21701777 0.98 PDK2 (0.43) PDK2ABCG2MYCGABRA1GABRG2
SCHEMBL21702216 0.98 ABCG2 (0.46) PDK2ABCG2MYCGABRA1GABRG2
SCHEMBL21701779 0.97 ABCG2 (0.45) PDK2ABCG2MYCGABRA1GABRG2
SCHEMBL22908080 0.97 ABCG2 (0.45) PDK2ABCG2MYCGABRA1GABRG2
SCHEMBL23257623 0.96 PDK2 (0.44) PDK2ABCG2MYCGABRA1GABRG2
SCHEMBL23257086 0.96 PDK2 (0.44) PDK2ABCG2MYCGABRA1GABRG2
SCHEMBL21342795 0.96 PDK2 (0.44) PDK2ABCG2MYCGABRA1GABRG2
SCHEMBL23257621 0.96 PDK2 (0.44) PDK2ABCG2MYCGABRA1GABRG2
SCHEMBL21701804 0.94 ABCG2 (0.42) PDK2ABCG2MYCGABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME CRY1, CRY2, CYP1A1 PDK2 1415/4885ABCG2 2349/4885MYC 1141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.